References
- Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
- Arnold M, Sierra MS, Laversanne M, et al. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2016. doi:10.1136/gutjnl-2015-310912. [Epub ahead of print].
- Brenner H, Altenhofen L, Stock C, et al. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1043–1051.
- Siegel R, DeSantis C, Virgo K, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–241.
- Brenner H, Stock C, Hoffmeister M. Effect of screening sigmoidoscopy and screening colonoscopy on colorectal cancer incidence and mortality: systematic review and meta-analysis of randomised controlled trials and observational studies. BMJ. 2014;348:g2467.
- Lin JS, Piper MA, Perdue LA, et al. Screening for colorectal cancer: updated evidence report and systematic review for the US preventive services task force. JAMA. 2016;315(23):2576–2594.
- Stock C, Knudsen AB, Lansdorp-vogelaar I, et al. Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc. 2011;73(3):435–443 e435.
- Zauber AG. The impact of screening on colorectal cancer mortality and incidence: has it really made a difference? Dig Dis Sci. 2015;60(3):681–691.
- Brenner H, Schrotz-king P, Holleczek B, et al. Declining bowel cancer incidence and mortality in Germany. Dtsch Arztebl Int. 2016;113(7):101–106.
- Lansdorp-vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33:88–100.
- Schreuders EH, Ruco A, Rabeneck L, et al. Colorectal cancer screening: a global overview of existing programmes. Gut. 2015;64(10):1637–1649.
- Steele RJ, McClements PL, Libby G, et al. Patterns of uptake in a biennial faecal occult blood test screening programme for colorectal cancer. Colorectal Dis. 2014;16(1):28–32.
- Malila N, Palva T, Malminiemi O, et al. Coverage and performance of colorectal cancer screening with the faecal occult blood test in Finland. J Med Screen. 2011;18(1):18–23.
- Kapidzic A, Grobbee EJ, Hol L, et al. Attendance and yield over three rounds of population-based fecal immunochemical test screening. Am J Gastroenterol. 2014;109(8):1257–1264.
- Centers for Disease Control and Prevention. Vital signs: colorectal cancer screening test use–United States, 2012. MMWR Morb Mortal Wkly Rep. 2013;62(44):881–888.
- Holden DJ, Jonas DE, Porterfield DS, et al. Systematic review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med. 2010;152(10):668–676.
- Joseph DA, King JB, Miller JW, et al. Prevalence of colorectal cancer screening among adults–behavioral risk factor surveillance system, United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61(Suppl):51–56.
- Senore C, Inadomi J, Segnan N, et al. Optimising colorectal cancer screening acceptance: a review. Gut. 2015;64(7):1158–1177.
- Brenner H, Werner S, Chen H. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371(2):184–185.
- Brenner H, Altenhofen L, Stock C, et al. Prevention, early detection, and overdiagnosis of colorectal cancer within 10 years of screening colonoscopy in Germany. Clin Gastroenterol Hepatol. 2015;13(4):717–723.